Case studiesFakham
Private biotech CRO
$5M clinical-trial pipeline
A campaign focused on biotech teams progressing Phase II clinical trials and testing.
Published Updated
Reported results
The numbers reported.
$5Mnew pipeline
$750Kclosed business
Pipeline and opportunity values are potential value, not collected revenue. Contracted and closed values are as reported by the client. These outcomes reflect this client engagement and are not a guarantee of future performance.
Case study in briefReported outcomes
What did Seqnced do for Fakham?
01The challenge
Fakham needed to move beyond referral-led introductions and create conversations around active clinical-trial and testing requirements.
02The approach
Seqnced focused the campaign on biotech companies approaching relevant Phase II work and connected the offer to concrete testing needs.
03The outcome
- $5M in new testing opportunities
- $750K in closed business
- $5M in new testing opportunities
- $750K in closed business
Related work
